Brad Robling leads global venture capital investments as Vice President of Lilly Ventures. His expertise spans strategic transactions, including M&A and licensing, built on a foundation of experience at firms like Deloitte and a background from Indiana University Bloomington. He focuses on long-term investments in oncology, cardiometabolic, and immunology therapeutics.
He serves on the board of the AMR Action Fund, a global initiative to combat the growing threat of antimicrobial resistance.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.